id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-P-0291-0005,FDA,FDA-2002-P-0291,FDA/OC to Johnson & Johnson,Other,PAV-Petition Approval,2003-04-17T04:00:00Z,2003,4,,,2008-04-12T01:28:02Z,,0,0,090000648049eef0